IDEAYA Biosciences, Inc. (IDYA)
40.11
-1.66
(-3.97%)
USD |
NASDAQ |
Aug 28, 16:00
40.11
0.00 (0.00%)
After-Hours: 20:00
IDEAYA Biosciences Total Assets (Quarterly) : 1.310B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.310B |
| March 31, 2026 | 1.030B |
| December 31, 2025 | 1.109B |
| September 30, 2025 | 1.185B |
| June 30, 2025 | 1.041B |
| March 31, 2025 | 1.101B |
| December 31, 2024 | 1.124B |
| September 30, 2024 | 1.240B |
| June 30, 2024 | 973.66M |
| March 31, 2024 | 961.53M |
| December 31, 2023 | 649.32M |
| September 30, 2023 | 532.94M |
| June 30, 2023 | 527.56M |
| March 31, 2023 | 364.75M |
| December 31, 2022 | 387.97M |
| September 30, 2022 | 410.91M |
| Date | Value |
|---|---|
| June 30, 2022 | 338.01M |
| March 31, 2022 | 358.87M |
| December 31, 2021 | 381.35M |
| September 30, 2021 | 399.44M |
| June 30, 2021 | 328.40M |
| March 31, 2021 | 326.10M |
| December 31, 2020 | 298.27M |
| September 30, 2020 | 301.38M |
| June 30, 2020 | 184.51M |
| March 31, 2020 | 101.79M |
| December 31, 2019 | 113.00M |
| September 30, 2019 | 122.33M |
| June 30, 2019 | 133.36M |
| March 31, 2019 | 92.68M |
| December 31, 2018 | 96.54M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Incyte Corp. | 7.873B |
| Xencor, Inc. | 724.96M |
| UroGen Pharma Ltd. | 252.59M |
| MeiraGTx Holdings Plc | 396.45M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 110.79M |
| Shareholders Equity (Quarterly) | 1.199B |
| Debt to Equity Ratio | 0.0244 |
| Current Ratio | 10.45 |
| Net Debt Paydown Yield | -0.02% |